Chi Ma
Impact in
- Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Epigenetics and DNA Methylation 9
- Gut microbiota and health 6
- Genomics and Chromatin Dynamics 6
- RNA modifications and cancer 6
- Immunology 26
- Immune cells in cancer 14
- Immune Cell Function and Interaction 8
- Co-authors
- Tim F. Greten (38 shared papers)Joyce L. Hamlin (9 shared papers)Santosh R. D’Mello (4 shared papers)Qianfei Zhang (11 shared papers)José Medina‐Echeverz (5 shared papers)Tobias Eggert (4 shared papers)Mathias Heikenwälder (2 shared papers)Firouzeh Korangy (13 shared papers)
- Journals
- Molecular and Cellular Biology (5 papers)Cancer Immunology Research (5 papers)Journal of Biological Chemistry (4 papers)PLoS ONE (3 papers)Nature Communications (3 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Chi Ma
107 papers receiving 4.5k citations
Chi Ma's Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 1.2k
- Hepatology 375
- Cancer Research 598
- Geriatrics and Gerontology 119
- Oncology 906
Countries citing papers authored by Chi Ma
This map shows the geographic impact of Chi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Ma more than expected).
Fields of papers citing papers by Chi Ma
This network shows the impact of papers produced by Chi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Ma. The network helps show where Chi Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis Hit paper breakdown → | 2016 | 582 |
| 2 | Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression Hit paper breakdown → | 2016 | 456 |
| 3 | 1999 | 196 | |
| 4 | 2021 | 173 | |
| 5 | 1993 | 164 | |
| 6 | 2008 | 153 | |
| 7 | 2013 | 148 | |
| 8 | 2003 | 137 | |
| 9 | 2020 | 128 | |
| 10 | 2018 | 125 | |
| 11 | 2018 | 110 | |
| 12 | 2022 | 109 | |
| 13 | 2018 | 102 | |
| 14 | 2015 | 86 | |
| 15 | 2020 | 76 | |
| 16 | 2007 | 72 | |
| 17 | 2010 | 72 | |
| 18 | 2017 | 69 | |
| 19 | 2021 | 69 | |
| 20 | 2011 | 67 |
About Chi Ma
Chi Ma is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Epidemiology, having authored 109 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immune cells in cancer (14 papers), Epigenetics and DNA Methylation (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Immune Cell Function and Interaction (8 papers), Gut microbiota and health (6 papers), Genomics and Chromatin Dynamics (6 papers), RNA modifications and cancer (6 papers) and Endoplasmic Reticulum Stress and Disease (6 papers). The work is most often cited by research in Immunology (1.2k citations), Hepatology (375 citations), Cancer Research (598 citations), Geriatrics and Gerontology (119 citations) and Oncology (906 citations). Chi Ma has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Tim F. Greten, Joyce L. Hamlin, Santosh R. D’Mello, Qianfei Zhang, José Medina‐Echeverz, Tobias Eggert, Mathias Heikenwälder, Firouzeh Korangy, Xin Wei Wang and Bernd Heinrich. Their work appears in journals such as Molecular and Cellular Biology, Cancer Immunology Research, Journal of Biological Chemistry, PLoS ONE and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.